Thank you and good afternoon. Welcome to our Conference Call for the Quarter Ended June 30, 2022. My name's Dan Baker. I'm the President and CEO of NVE Corporation. This call is being webcast live and being recorded. A replay will be available through our website, nve.com. I'm joined by our CFO, Joe Schmitz. After my opening comments, Joe will present a financial review. Then I'll cover the business and new products. Then we'll open the call to questions. We issued our press release with quarterly results and filed our quarterly report on Form 10-Q in the past hour following the close of market. Links to the press release and 10-Q are available through the SEC's website, our website, and our Twitter timeline.
Comments we may make that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties, including, among others, such factors as risks and uncertainties related to future sales and revenue, uncertainties related to future stock repurchases and dividend payments, our dependence on critical suppliers and packaging vendors, and risks related to the COVID-19 pandemic and supply chain disruptions, as well as the risk factors listed from time to time in our filings with the SEC, including our annual report on Form 10-K for the fiscal year ended March 31st, 2022. Actual results could differ materially from the information provided, and we undertake no obligation to update forward-looking statements we may make. We're pleased to report a 16% increase in net income for the first quarter to $0.86 per diluted share. Joe will cover the details. Joe?
Thanks, Dan. Total revenue for the most recent quarter increased 3% to $7.34 million from $7.15 million in the prior year quarter. The increase was due to a 2% increase in product sales and a 32% increase in contract R&D revenue. Growth was from a strong quarter last year. Product sales increased 11% sequentially from the March quarter. We continue to be challenged by supply chain shortages, although we're seeing signs of improvement. During the quarter, deliveries from our supply base enabled NVE to increase work in process inventory by $508,000 to support future growth. We're picking up new customers from traditional semiconductor companies with our superior products and shorter lead time. We've increased our capacity with new equipment.
We expect to invest as much as $1 million in additional production and test equipment in the rest of the fiscal year. Gross margin was 77% for the quarter, compared with 75% last year. Margins decreased last year because of cost increases in the semiconductor industry. The price increases we enacted in the prior fiscal quarter are beginning to offset increased costs. Expenses for the quarter decreased 24% from the prior year due to a 26% decrease in R&D and a 20% decrease in SG&A. The decrease in R&D was due to R&D personnel spending more time on revenue-generating activities. The decrease in SG&A was due to lower incentive compensation.
Interest income for the quarter decreased 2% due to the timing of maturities for available-for-sale securities, and in late June and early July, we reinvested those proceeds from maturing securities at higher interest rates. Driven by increased revenue, increased margins, and decreased expenses, net income for the quarter increased 16% to $4.14 million, or $0.86 per diluted share, compared to $3.58 million or $0.74 per share for the prior quarter. In addition to the increase in gross profit margin, operating margin, pre-tax margin, and net margins all increased compared to the prior-year quarter. Net margin was a strong 56%, and we recorded our largest quarterly profit since 2018.
In addition to the past quarter's $1 per dividend, today we announced that our board declared another quarterly dividend of $1 per share, payable August 31, to shareholders of record as of August 1st. Now I'll turn it back to Dan to cover the business, new products, and marketing.
Thanks, Joe. In-person trade shows and conferences are returning. We exhibited at Sensors Converge in San José a few weeks ago. The exhibition showcases the latest sensing technologies and was back to its traditional early summer schedule for the first time since the pandemic. We received a number of new leads and continue to follow up. In an industry racked by shortages, a number of prospects were impressed by our inventory levels and lead times. We demonstrated several new products, and we had a mechatronic demonstration of using one of our new smart sensors to control a musical pitch pipe. Musical instrument robots have been effective in attracting attention and demonstrating the precision, robustness, and simplicity of our sensors. We also had sales staff supporting distributors at two major trade shows in Germany the past quarter, PCIM Europe and SENSOR+TEST. Both shows reach important target markets for us.
PCIM is billed as the world's leading exhibition and conference for power electronics, intelligent motion, renewable energy, and energy management. SENSOR+TEST claims to be the world's leading forum for sensor measurement and testing technology. I've been asked about our Ukrainian distributor, Kvazar-Micro, which is based in Kyiv, and has represented us for more than 15 years. It's not significant business for us from a financial perspective, but it is inspirational, and we continue to have sales dialogue and to expedite their orders. They've helped inspire us to do our damnedest to overcome supply chain challenges. Turning to new products, we introduced a new ultra-miniature version of our Tunneling Magnetoresistance, or TMR magnetic sensors. The new parts are 1.1 mm, less than a 16 of an inch square.
The existing parts were already pretty small, 2.5 mm, less than 0.1 inch. We believe the new part is the smallest device of its type and can be used to detect position in tight spaces such as industrial or medical robots as they get smaller. There's a demonstration video on our website and YouTube channel. Our components are inherently safer and more reliable than legacy semiconductors. An industry standard for that is called Intrinsically Safe. In the past quarter, several of our data coupler models were certified for use as isolating components in Intrinsically Safe circuits by Underwriters Laboratories. Our couplers transfer data without direct electrical connections to hazardous areas. This mitigates the risk of arcing or otherwise starting an explosion. Certification involves rigorous testing by UL and a thorough on-site audit of our control over product safety processes.
It's a great validation of our technology and manufacturing capabilities, and it's valuable in hazardous areas of the Internet of Things, such as chemical or food processing plants. Three isolator lines have intrinsically safe certified versions, our flagship data couplers, Isolated Network Transceivers, and our low-power Tunneling Magnetoresistance data couplers. There's an intrinsic safety demonstration on our YouTube channel, where we also destroy a competitive part. We're fortunate to have dedicated employees. We make things, so working from home isn't an option. Our employees have worked through the personal challenges of the pandemic, industry shortages, and supply chain problems. I was able to thank them as a group at our first in-person employee meeting in more than two years last quarter. We had a barbecue to welcome spring in Minnesota. We demonstrated new products for our employees and celebrated the foundation our employees have built for a bright future.
As promised in last year's proxy, we will return to in-person annual shareholders meetings with our meeting at a nearby hotel and conference center on August 4th. The first annual meeting agenda is the election of directors, and we're pleased to have a strong independent board of directors with two former public company CEOs, Rich Kramp and Jim Bracke, a former CFO of a public company, Pat Hollister, an experienced director for a number of successful public companies, Terry Glarner. The second annual meeting agenda item is approval of officer compensation. As detailed in our proxy, we don't overpay our officers. Our officers have the same fringe benefits as all employees, and there are no executive perks or golden parachutes. The third annual meeting agenda item is ratification of our auditors for this fiscal year, the year ending March 31st, 2023 .
Boulay has audited our past three fiscal years, and we recommend their approval for our next audit. A popular feature of our in-person annual meetings has been live hands-on product demonstrations, and we'll have several of those. If you can't attend, you can see the product demonstrations, a number of product demonstrations on our website or our YouTube channel. Now I'd like to open the call for questions. Operator?
Certainly. Ladies and gentlemen, if you have a question at this time, please press star then one. One moment for our first question. Our first question comes from the line of Jeffrey Bernstein from Cowen. Your question, please.
Joe, nice to talk to you today, and congratulations on looks like the best EPS in several years, so that's great. Wanted to ask you a little bit about Abbott. I guess you guys had renegotiated your deal with them good through the end of this year, and I'm just curious about where that stands now, kind of what you think the term of the next renewal might look like.
Yeah, we're still in the midst of those negotiations. We've had a number of sessions with our counterparts at Abbott. We're still in the middle of working out the details, but what I can report is that there's been strong engagement on both sides, and you know, we're looking forward to successfully concluding a long-term agreement with them.
About how long of a long-term agreement would that be? Would that be several years?
Of course, that's one of the negotiating items, obviously. We are advocating for a longer term, but,
Gotcha.
That remains to be seen. The next agreement, I believe, will be a multiyear agreement.
Gotcha. Okay. Just curious, you know, their business looked strong this morning for the most part, particularly in the heart failure area, which, you know, implantable defibrillators. I'm just curious, I think you guys are in the, you know, cardiac rhythm management generally, so pacemakers and defibrillators. If there's much of a difference in content across those different categories and also, I think you're in neuromodulators as well.
Right. This is Dan. While typically there's more functionality in an ICD, an implantable cardioverter defibrillator than a pacemaker, we're counting our businesses based on the number of sensors, which tend to be comparable. For us, there's not a huge distinction between CRM devices. We provide the same level of functionality. There isn't a direct correlation between our revenue and their revenue.
Gotcha. Okay. And then they do have a couple of new pretty promising sounding products in that area, this new Aveir single- chamber leadless pacemaker that doesn't need a chest pocket incision. This thing looks like it's about the size of a little cold pill. I know you can't say whether you're in it, but is there a reason to believe that it would not need the same functionality that you provide to their other products?
I appreciate your elegant wording of the question, Jeff. The miniaturization is really amazing in some of these devices, and our products uniquely support miniaturization. We have the world's smallest devices of their type. We just talked about one in the prepared remarks that's not necessarily for design for medical devices, but it highlights the advantages that we have with our spintronic technology of being able to make the world's smallest devices. I would imagine that's a benefit that's very important as medical devices get smaller and smaller. The smaller they get, of course, the less invasive they are, the more people that can get the therapy, so it drives long-term growth. We like to see that trend and we like to support it.
Gotcha. Okay. I guess the same would sort of follow for this, implantable deep brain stimulator for the treatment of resistant depression, or bear market depression, I guess, which hasn't been approved yet, but they have a breakthrough designation for. The same concept would apply to that.
Yes. We've talked about in the past as you know, Jeff, we've talked about extending our technology to other types of neurostimulators, such as deep brain stimulators, which are relatively small markets now, but which have excellent growth potential to treat new types of diseases like drug-resistant depression, which is a significant medical issue. That's something that we think is a good development. Again, we design, as you pointed out, we design sensors that allow smaller implantable medical devices. You can imagine that for something like a deep brain stimulator, that would be an important benefit, the smaller size.
As you mentioned, with the breakthrough designation, the system could be available as a new treatment option sooner for treatment of resistant depression. It's currently investigational use, but it is already used to treat movement disorders such as Parkinson's disease. That's a growing market area and an opportunity to help more and more people.
That's great. Can you talk about any progress with the Angst+Pfister , you know, hybrid EV onboard charger reference design?
We continue to get inquiries and leads for devices both onboard charging and the charging systems for hybrid Electric Vehicles, as well as for other types of motor controls and charging systems. It's an important area for us, and it uses a number of our products. We recently did a demonstration showing how we can use our isolators, our DC- to- DC converters, and our angle sensors to run a highly efficient motor. Now, we wouldn't need the angle sensors, we don't need the angle sensors for things like the Angst+Pfister system, which is for battery charging. We can do the battery charging with our DC- to- DC converters and our isolators.
They allow much faster systems, much higher speed systems, which means more efficiency for energy conversion, either energy conversion to charge batteries in the case of the Angst+Pfister system or to run a motor in the case of motor control systems, where we've been offering a number of components. It's an important market area for us. We see excellent potential for growth, and there's more and more emphasis on energy efficiency, and that's what our systems help to do, our products help to do that.
Can you talk a little bit about the newer distributors you've added, I guess, a Japanese distributor and an Indian distributor?
Yes. Well, we've received good activity from our new distributors. As you might expect, sometimes they're asking questions that our more experienced distributors don't ask, but that's great, and that's all part of the process. We provide them excellent support. We help them understand the markets that our products are used in. We help them understand our benefits compared to conventional technology, and we try to provide them with excellent design support when they have specific questions from their customers. It's an important part of it. It's the main way we reach our market. Having great distributors, we feel very fortunate that we've got excellent distributors. They're very technically good, as well as being good salespeople.
We're pleased with what we've seen so far, and particularly in India, which is a very fast-growing market, and of course, a very large country. We have now several distributors covering most of the major areas in India.
Dan, can you give us an update on what your lead times look like, you know, versus competitors? I would think that would be pretty appealing to both customers and distributors.
Yeah. It is indeed. We just answered that question for a particular customer on a particular part, and our lead time for that part was running. I'm giving this as an example, of course the lead times can vary. The part, our part was approximately 12-week lead time, and a competitive conventional semiconductor part was approximately 84- weeks. Those were lead times that we pulled off of a distributor, one of our distributors who also distributes some competitive products. As you can imagine, that's a pretty attractive benefit proposition. In addition, we have better parts. They're more reliable, they have better specifications, higher speed, and longer barrier life.
We are picking up a number of new leads for customers who are attracted by the lead times. We're glad they're attracted by the lead times, but we're also very optimistic that they're gonna stay for the quality of the products, the quality of the support they get, and that they're gonna be able to use the advantages that we have over conventional semiconductors.
This is kind of giving you a one-time, you know, opportunity to you know, steal some share from competitors, at least raise your profile, get in front of people, with customers now willing to do board redesigns and that kind of thing. Can you just talk about, you know, how we should think about that impact to your top line and seeing that?
Right. As you say, it should have a near-term benefit to our top line when we're delivering some of those. We'll be delivering more of those new design wins. Our hope is that it overcomes some of the trepidation, I suppose, that some companies have about working with a smaller company. We recognize that we may not be a household name like one of the large semiconductor conglomerates, but we provide excellent products, excellent support and service, and excellent on-time delivery performance and short lead times. We hope that however these customers came to us, we're very optimistic that they're gonna stay with us because we're confident that we're going to be an excellent supplier for them. We have excellent supplier ratings and always have.
The challenge is we retain a very high percentage of our customers. The challenge is reaching them as a small company. I suppose the silver lining of the shortages that we're seeing in the industry is that we're able to reach customers who we may not have reached before, and we're determined to retain them.
Now you guys said it. You attributed the growth in the quarter to pricing. I'm sort of wondering, you know, what's going on with units? Are units down? Is that a, you know, sort of supply chain kind of issue or, you know, what's the story on units?
Well, to your point, we attributed our product sales absolutely to some pricing actions, but we also had some pretty strong R&D revenue as well. We gotta be a little bit careful when you call that. Talking about units is always a little bit difficult because of the different product mix, but so I would not say that higher revenue from sales equates to lower unit volume. I don't think that's the case at all based on what we were putting through our facility. I think in that sense, you know, the higher price was obviously better margins, but I don't think that equates to lower unit volume.
Understand. Okay. Thanks very much for the time, guys.
Thanks, Jeff.
Thank you. Once again, if you have a question at this time, please press star, then one. Our next question comes to the line of Chris Wieczerkowski from Private Investor. Your question please.
Congratulations on great results.
Thanks, Chris.
I would like to continue on that theme of the previous question about the fact that you're picking up orders because of your shorter lead times and your ability to keep those customers. Now, I always kind of viewed you as kind of like a really like the highest quality, you know, the highest quality sensor manufacturer. That's why you have the, you know, the MRI machines and, you know, pacemakers and so on, and also the most expensive one. You know, even if you do provide great service, how would you ensure that those clients that picked you for your, you know, for your availability now wouldn't go to the lower price sensors when they become available?
In other words, can you point to savings on the PCB, you know, fewer component counts or any other kind of savings that the higher quality of your components would allow?
Yes, that's a great point, Chris. First of all, we can point to advantages that save our customers money. One of them is chip count, particularly with our DC-to-DC converter parts. Another is reliability. Sometimes that's an intangible cost, but it's important to many of our customers. Then finally, size, which reduces PCB size in the case of industrial customers. We talked about the obvious advantages in the case of implantable medical devices, but it's also an advantage in industrial devices too, because circuit boards, as you know, are priced by the square inch. While we offer the highest quality, our prices are competitive. We have top of the line products, but our prices are reasonable. We're also, in many cases, a relatively low share of budget.
The components that we make enable a very expensive system. We believe that our parts are fairly priced. The biggest challenge that we've faced is brand awareness and the perceived risk of working with a smaller company. The shortages and our shorter lead times help us overcome that. We believe that we'll retain a large percentage of these new customers and the new business that we're getting.
I guess I'd like to add one point to what Dan just said, too. One of the things that I've observed is, as we get to know some of these customers who, yes, are coming to us, you know, out of an extreme need for product, you know, once we begin working with them and understand their business, we've had, in some cases, been able to offer different configurations, different specs of parts that you know, allow them to meet, you know, a price target that they may have. I've seen some of that ongoing dialogue take place, and to me, that's a value proposition for the customer to help them, you know, right-size their product, so to speak.
Okay, that's good to hear. You know, in case you get designed in some high volume applications, are you able to ramp up your volumes?
That is something as we talked about in our pre-prepared comments, we are building that capacity. We will be spending, as I said, upwards of $1 million this year. We believe that we'll be prepared for that step volume change in function. We're also looking to add people to some of our second and third shift operations. Challenge, particularly given the supply chain constraints, but that's what we are aspiring to do.
Good to hear again. Another question on automotive. I've been following many automotive semi companies, and it seems that it's a very time-consuming process to get design into like a, you know, large- volume automotive platform, and it ends up being rewarded in the end, but it's very time-consuming. You know, you told us some, you know, encouraging news, but can you tell us, like, where are you in the designing process and perhaps maybe in the place. I know you have, like, many applications, but in the application where you're closest to a high volume automotive platform, where are you-
Yeah.
In the designing process?
Right. As you say, it's a large endeavor. It's one we've committed to at NVE to reach the automotive market. We do that through our own efforts and also through private label partnerships with companies that have strong presence in the automotive industry. It is time-consuming, but we're willing to spend the time and to make the investments. We have also achieved International Automotive Task Force or IATF conformance with their quality standards, which is a rigorous process and bolsters our credibility in that market.
As far as the specific parts, the ones that are the farthest along are isolators and especially for CAN, Controller Area Network buses, which are one of the key network backbones in all cars, especially hybrid electric vehicles, but they're also in ICE and internal combustion-based cars as well. Those parts, we have some interest. We don't have any really high volume in-car applications. We have some applications in automotive factories that are in production. That's sometimes a natural segue into in-car applications, which I think is what you're asking, because they tend to be higher volume. But being able to interface to the car in the factory is also important. We believe that we're reasonably close on some applications for Controller Area Network transceivers.
We'll have to see, and we're not, we don't have any in full production in-car applications at this point.
Okay. Thanks for that. Great results again. That's it for me. Good luck in the future.
Thanks, Chris.
Thank you.
One moment for our next question. Our next question comes from the line of Alex Woodward from Bridge City Capital. Your question, please.
Yeah, good afternoon, gentlemen. I wanted to ask about the increase in inventory and specifically, you know, it's up half a million dollars. The work in process is sequentially. If you go back and look year-over-year, it's up almost $1.5 million. How much of this is maybe orders that you have or commitments that you have versus just building to spec and hoping it'll ship as opposed to knowing it's gonna ship?
The vast majority of it is to meet existing orders.
Very good. With the increase, you know, $500,000 sequentially, is that an indication that you feel good about the near-term prospects for sequential growth, maybe too, you know, your earnings are within a couple pennies of the level that was set in 2018. Your revenue is still a little bit ways away from where you got in 2018. With what's going on in the industry, is NVE looking to have a record year? I know you guys don't guide, but the numbers on the balance sheet would indicate that you're positioned for growth. I'm asking is, you know, fiscal 2023 gonna be a growth year for the company and maybe take it to new levels?
It's always a difficult one to answer. I think we've got a lot of challenges. As I mentioned, we're working against a very strong order flow. Are seeing some of our segments with some nice growth prospects. You know, we're trying to hit our commitments to our customers. We think that's gonna get us to a good place by the end of the year. Lots of challenges ahead of us.
Given 12- months might be a little bit of a reach to know what the visibility looks like there, the near-term visibility, and you just commented on strong orders, should we expect sequential growth in the September quarter?
I think, we're gonna try and do everything we can to hit that.
It's certainly our goal to grow. As Joe mentioned, we've been very pleased with the order flow.
It's great to hear because, you know, for a long time the revenues feels like it's kind of gotten to these levels, and then it's kind of stagnated, and it's been hard to break through. Another data point that I'm encouraged with is the, you know, the increase in CapEx and the incremental capacity. That's another sign that you're looking to grow. At least that's what I see from my perspective. Am I reading that wrong?
Joe, I think Joe and I were gonna answer it the same way. No, we're making those investments because we see the potential. We have the order flow, and we need to increase our capacity. That's what we're doing. It's reflected in the WIP, and it's reflected in what Joe was talking about in our capital planning.
Great. The last question I have is, and this is kind of not why we're invested, but I think it might have an effect. You have a pretty big cash balance, and the interest income has been fairly stable. You said that some of the investments matured and you reinvested them. What is that gonna do to the interest income line going forward, especially with interest rates higher and likely likelihood of rates increasing even further?
Yeah. You know, as you can see from our quarterly filing, you know, we're gonna be doing this reinvestment three or four more times here over the next 60 days. We are seeing better interest rates. You know, I'm gonna say that we've seen things, and we've all been watching what the treasury bills, the five-year Treasury bond is doing. We're benefiting from that now. I'm thinking we'll capture a little bit higher interest rates and a little bit higher interest income as a result of that, yes.
Great. Thank you for the opportunity to ask a question or two.
Thank you. Good question. Appreciate it.
Thanks, Alex.
Thank you. This does conclude the question and answer session of today's program. I'd like to hand the program back to management for any further remarks.
We were pleased to report a 16% earnings increase on our largest quarterly profit since 2018. We look forward to meeting some of you at our shareholders meeting in a couple of weeks, and our next Earnings Call will be in October. Thank you for participating in the call.
Thank you, ladies and gentlemen, for your participation. This does conclude the program. You may now disconnect. Good day.